Simvastatin and Other HMG-CoA Reductase Inhibitors on Brain Cholesterol Levels in Alzheimer's Disease

E-ISSN： 1875-5828|8|4|434-442

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.8, Iss.4, 2011-06, pp. : 434-442

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protective effect of pitavastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, on ischemia-induced neuronal damage

By Kurosaki R. Muramatsu Y. Kato H. Araki T.

Neurological Research, Vol. 26, Iss. 6, 2004-09 ,pp. : 684-691

Maney Publishing

Access to resources Recommend Favorite

The Role of Brain Cholesterol and its Oxidized Products in Alzheimer's Disease

Current Alzheimer Research, Vol. 13, Iss. 2, 2016-02 ,pp. : 198-205

Bentham Science Publishers

Access to resources Recommend Favorite

Cholesterol, A and Alzheimer's disease

By Hartmann T.

Trends in Neurosciences, Vol. 24, Iss. 11, 2001-11 ,pp. : 45-48

Elsevier

Access to resources Recommend Favorite

Pitavastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, reduces hippocampal damage after transient cerebral ischemia in gerbils

By Kumagai R. Oki C. Muramatsu Y. Kurosaki R. Kato H. Araki T.

Journal of Neural Transmission, Vol. 111, Iss. 9, 2004-09 ,pp. : 1103-1120

Springer Publishing Company

Access to resources Recommend Favorite

Alzheimer’s disease: amino acid levels and brain metabolic status

By Gueli Maria Taibi Gennaro

Neurological Sciences, Vol. 34, Iss. 9, 2013-09 ,pp. : 1575-1579

Springer Publishing Company

Access to resources Recommend Favorite